Connection

Wen-Chien Ko to Pandemics

Back to Details
This is a "connection" page, showing publications Wen-Chien Ko has written about Pandemics.
Wen-Chien Ko
Connection Strength
0.057
Pandemics
  1. COVID-19 in long-term care facilities: An upcoming threat that cannot be ignored. J Microbiol Immunol Infect. 2020 Jun; 53(3):444-446.
    View in: PubMed
    Score: 0.007
  2. Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status. Int J Antimicrob Agents. 2020 Apr; 55(4):105946.
    View in: PubMed
    Score: 0.007
  3. A case of COVID-19 and pneumonia returning from Macau in Taiwan: Clinical course and anti-SARS-CoV-2 IgG dynamic. J Microbiol Immunol Infect. 2020 Jun; 53(3):485-487.
    View in: PubMed
    Score: 0.007
  4. Arguments in favour of remdesivir for treating SARS-CoV-2 infections. Int J Antimicrob Agents. 2020 04; 55(4):105933.
    View in: PubMed
    Score: 0.007
  5. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths. J Microbiol Immunol Infect. 2020 Jun; 53(3):404-412.
    View in: PubMed
    Score: 0.007
  6. National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) programme in 2017-2020. J Glob Antimicrob Resist. 2021 09; 26:308-316.
    View in: PubMed
    Score: 0.002
  7. Increased antimicrobial resistance during the COVID-19 pandemic. Int J Antimicrob Agents. 2021 Apr; 57(4):106324.
    View in: PubMed
    Score: 0.002
  8. The impact of the coronavirus disease 2019 epidemic on notifiable infectious diseases in Taiwan: A database analysis. Travel Med Infect Dis. 2021 Mar-Apr; 40:101997.
    View in: PubMed
    Score: 0.002
  9. The occurrence of and risk factors for developing acute critical illness during quarantine as a response to the COVID-19 pandemic. J Formos Med Assoc. 2022 Jan; 121(1 Pt 1):81-88.
    View in: PubMed
    Score: 0.002
  10. Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan. Emerg Microbes Infect. 2020 Dec; 9(1):2157-2168.
    View in: PubMed
    Score: 0.002
  11. Application of an Artificial Intelligence Trilogy to Accelerate Processing of Suspected Patients With SARS-CoV-2 at a Smart Quarantine Station: Observational Study. J Med Internet Res. 2020 10 14; 22(10):e19878.
    View in: PubMed
    Score: 0.002
  12. Anosmia and olfactory tract neuropathy in a case of COVID-19. J Microbiol Immunol Infect. 2021 Feb; 54(1):93-96.
    View in: PubMed
    Score: 0.002
  13. In vitro diagnostics of coronavirus disease 2019: Technologies and application. J Microbiol Immunol Infect. 2021 Apr; 54(2):164-174.
    View in: PubMed
    Score: 0.002
  14. Extra-respiratory manifestations of COVID-19. Int J Antimicrob Agents. 2020 Aug; 56(2):106024.
    View in: PubMed
    Score: 0.002
  15. Continuous temperature monitoring by a wearable device for early detection of febrile events in the SARS-CoV-2 outbreak in Taiwan, 2020. J Microbiol Immunol Infect. 2020 Jun; 53(3):503-504.
    View in: PubMed
    Score: 0.002
  16. SARS-CoV-2 and COVID-19. J Microbiol Immunol Infect. 2020 Jun; 53(3):363-364.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.